Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...

The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors�reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...

The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Lag ja Gale Part 2 (Ullu) Web Series: Lag ja Gale Part 2 is a Ullu web series. In this web series, Subhati Das, Pihu Singh, Anjita Adhikari, Sunil, Akshay played the lead role. Lag ja Gale Part 2 was ...

In 2024, we presented data showing the treatment with a triple blockade of PVRIG, TIGIT and PD-1 with COM701 ... We believe ...

In 2024, we presented data showing the treatment with a triple blockade of PVRIG, TIGIT and PD-1 with COM701 ... And off hand, I think it’s about 1/3 of patients that have the mutation.